KINETICS AND MECHANISM OF AUTOPROCESSING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE FROM AN ANALOG OF THE GAG-POL POLYPROTEIN

被引:87
|
作者
LOUIS, JM
NASHED, NT
PARRIS, KD
KIMMEL, AR
JERINA, DM
机构
[1] NIDDKD,BIOORGAN CHEM LAB,BETHESDA,MD 20892
[2] NIDDKD,CELLULAR & DEV BIOL LAB,BETHESDA,MD 20892
[3] NIDDKD,MOLEC BIOL LAB,BETHESDA,MD 20892
关键词
D O I
10.1073/pnas.91.17.7970
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Upon renaturation, the polyprotein MBP-Delta TF-Protease-Delta Pol, consisting of HIV-1 protease and short native sequences from the trans-frame protein (Delta TF) and the polymerase (Delta Pol) fused to the maltose-binding protein (MBP) of Escherichia coli, undergoes autoprocessing to produce the mature protease in two steps. The initial step corresponds to cleavage of the N-terminal sequence to release the protein intermediate Protease-Delta Pol, which has enzymatic activity comparable to that of the mature enzyme. Subsequently, the mature enzyme is formed by a slower cleavage at the C terminus. The rate of increase in enzymatic activity is identical to that of the appearance of MBP-Delta TF and the disappearance of the MBP-Delta TF-Protease-Delta Pol. Initial rates are linearly dependent on the protein concentration, indicating that the N-terminal cleavage is first-order in protein concentration. The reaction is competitively inhibited by pepstatin A and has a pH rate profile similar to that of the mature enzyme. These results and molecular modeling studies are discussed in terms of a mechanism in which a dimeric full-length fusion protein must form prior to rate-limiting intramolecular cleavage of the N-terminal sequence that leads to an increase in enzymatic activity.
引用
收藏
页码:7970 / 7974
页数:5
相关论文
共 50 条
  • [41] MATURATION OF HUMAN-IMMUNODEFICIENCY-VIRUS PARTICLES ASSEMBLED FROM THE GAG PRECURSOR PROTEIN REQUIRES INSITU PROCESSING BY GAG POL PROTEASE
    ROSS, EK
    FUERST, TR
    ORENSTEIN, JM
    ONEILL, T
    MARTIN, MA
    VENKATESAN, S
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (05) : 475 - 483
  • [42] THE GAG PROTEINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - MECHANISMS OF VIRUS ASSEMBLY AND POSSIBILITIES FOR INTERFERENCE
    MODROW, S
    KATTENBECK, B
    VONPOBLOTZKI, A
    NIEDRIG, M
    WAGNER, R
    WOLF, H
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1994, 183 (04) : 177 - 194
  • [43] Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo
    Zennou, V
    Mammano, F
    Paulous, S
    Mathez, D
    Clavel, F
    JOURNAL OF VIROLOGY, 1998, 72 (04) : 3300 - 3306
  • [44] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG PROTEINS ARE PROCESSED IN 2 CELLULAR COMPARTMENTS
    KAPLAN, AH
    SWANSTROM, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) : 4528 - 4532
  • [45] ADVANCES IN AUTOMATED DOCKING APPLIED TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE
    MILLER, MD
    SHERIDAN, RP
    KEARSLEY, SK
    UNDERWOOD, DJ
    RETROVIRAL PROTEASES, 1994, 241 : 354 - 370
  • [46] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [47] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [48] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [49] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PEDERSEN, C
    DANISH MEDICAL BULLETIN, 1994, 41 (01) : 12 - 22
  • [50] THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF GENE - THE ROAD FROM AN ACCESSORY TO AN ESSENTIAL ROLE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    VOLSKY, DJ
    POTASH, MJ
    SIMM, M
    SOVA, P
    MA, XY
    CHAO, W
    SHAHABUDDIN, M
    TRANSACTING FUNCTIONS OF HUMAN RETROVIRUSES, 1995, 193 : 157 - 168